2020 Annual Meeting | C177 - The Global Burden of Neurologic Diseases
07:00 AM - 07:35 AM | Speaker |
Neurology in Refugees and Asylum Seekers
Farrah J. Mateen, MD, PhD, FAAN |
07:35 AM - 08:10 AM | Speaker |
Burden of Stroke in Resource-Limited Settings
Cumara B. O'Carroll, MD, FAAN |
08:10 AM - 08:45 AM | Speaker |
The Disease that Shall Not Be Named: Epilepsy Care and Research in Zambia
Omar Siddiqi, MD |
08:45 AM - 09:00 AM | Q&A |
Questions & Discussion
|
Cumara B. O'Carroll, MD, FAAN | Dr. O'Carroll has nothing to disclose. |
Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
Omar Siddiqi, MD | The institution of Dr. Siddiqi has received research support from NIH. |